IP
ACAD icon

Intellectus Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Intellectus Partners’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-200
Closed -$4K – 268
2018
Q3 		$4K Hold
200
– – ﹤0.01% 537
2018
Q2 		$3K Hold
200
– – ﹤0.01% 550
2018
Q1 		$4K Hold
200
– – ﹤0.01% 544
2017
Q4 		$6K Hold
200
– – ﹤0.01% 521
2017
Q3 		$8K Hold
200
– – ﹤0.01% 631
2017
Q2 		$6K Hold
200
– – ﹤0.01% 646
2017
Q1 		$7K Hold
200
– – ﹤0.01% 559
2016
Q4 		$6K Buy
+200
New +$5.29K ﹤0.01% 563

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return